Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Tachycardia, Ventricular
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The study purpose is to demonstrate that ventricular tachycardia (VT) ablation using the Niobe™ ES system results in superior outcomes compared to a manual approach in subjects with ischemic scar VT in a low ejection fraction population.

Provided treatments

  • Device: catheter ablation using magnetic navigation
  • Device: catheter ablation using manual navigation
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02637947. The sponsor of the trial is Stereotaxis and it is looking for 386 volunteers for the current phase.
Official trial title:
A Prospective, Multi-center, Post Market Randomized Controlled Trial Comparing VT Ablation Outcomes Using Remote MAGNETIC Navigation Guided Substrate Mapping and Ablation Versus Manual Approach in a Low LVEF Population